Objectives: To assess the incorporation of n-3 polyunsaturated fatty acids (PUFA) in plasma and erythrocyte lipids of elderly subjects after ingestion of very low doses of ®sh oil. The effects on a-tocopherol and retinol concentrations were also studied. Setting: Municipal nursing home in Barcelona, Spain. Subjects: Forty-®ve elderly subjects aged 60±92 y. Design and intervention: Subjects received a non-commercialized milk formula containing 1% ®sh oil for 15 months, which provided 0.40 g/d of n-3 PUFA. Fatty acid pro®les and antioxidant concentrations were measured before and after the intervention period. Results: Fish oil ingestion was associated with signi®cant increases in total n-3 PUFA in plasma and erythrocytes by 32% and 18%, respectively. Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid concentrations were higher after the ingestion period both in plasma and erythrocytes (P`0.05), whereas linoleic and arachidonic acids remained unchanged. The n-6/n-3 ratio decreased by 21% in plasma and by 16% in erythrocytes (P`0.05). Moreover, younger subjects showed a greater incorporation of EPA and DHA than older subjects. Plasma a-tocopherol and retinol concentrations did not vary signi®cantly, whereas erythrocyte atocopherol was signi®cantly higher after the intervention period. Conclusion: This study shows that low doses of n-3 PUFA supplemented with adequate amounts of a-tocopherol can be incorporated into blood lipids in elderly subjects without lowering their antioxidant concentrations. Sponsorship: This study was supported by a research grant from the Spanish CDTI.
Introduction
With age there is a progressive and marked increase in the risk of development of coronary heart disease, which is the leading cause of death in Western industrialized countries. Many factors are implicated in the development of coronary heart disease: genetic factors, hypertension, high plasma levels of low density lipoproteins, low levels of high density lipoproteins, diabetes mellitus, stress, some adverse behaviors such as cigarette smoking and also dietary factors are among the most relevant (Kinsella et al, 1990) . Epidemiological studies reported that populations with a high consumption of ®sh such as the Greenland Eskimos and the Japanese showed a low incidence of coronary heart disease, which was attributed to n-3 polyunsaturated fatty acids (PUFA) derived from ®sh and specially to eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids (Bang et al, 1971; Bang et al, 1976) . Since this observation was made, a number of studies have con®rmed the bene®cial effect of n-3 PUFA in the prevention of cardiovascular disease (Kromhout et al, 1985; Leaf & Weber, 1988) . These fatty acids appear to modulate eicosapentaenoic metabolism and lower serum triglycerides, and thus may have potential for the amelioration of atherogenesis and thrombosis (Kinsella et al, 1990; Simopoulos, 1991) . In addition, other bene®cial effects have been described for n-3 PUFA in the treatment of arthritis, psoriasis, lupus, cancer and diabetes (Simopoulos, 1991) , which are common diseases in elderly people.
Most studies of the effect of n-3 PUFA supplementation on coronary heart disease have been performed using high doses of ®sh oil or n-3 PUFA over a short period of time (Mori et al, 1987; Cobiac et al, 1991) , but very few of them have administered low doses over a long period. Moreover, a number of studies have been carried out on adult men and women (von Schacky et al, 1985; DeLany et al, 1990; Nelson et al, 1991) , but little information is available about the role of n-3 PUFA in elderly individuals.
The aim of this study was to assess incorporation of n-3 PUFA in blood lipids in a group of elderly subjects after ingestion of low amounts of ®sh oil over a long period of time. However, n-3 fatty acids are highly susceptible to lipid peroxidation and therefore may contribute to an overall enhancement of prooxidant stress in the body (Garrido et al, 1989; Oostenburg et al, 1994) . Many studies have shown that enrichment of n-3 PUFA in the diet, even in low amounts, may result in lower concentrations of endogenous antioxidants such as vitamin E and indirectly affect other labile micronutrients such as retinol (Nair et al, 1993; Wolmarans et al, 1993) . For this reason, another aim of this study was to study the effects of ®sh oil adminis-tration on a-tocopherol and retinol concentrations in the blood.
Methods
The study was carried out on a group of elderly people residing in a nursing home in Castelldefels (Barcelona). Fifty elderly subjects (21 men, 29 women) between the ages of 60 and 92 y were enrolled according to the following conditions: they had no endocrine diseases, they took no medication or drugs known to affect metabolism or heart functionality, they were not cigarette smokers, their consumption of alcohol was not excessive (`40 g/d) and they were willing to cooperate. Subjects had been living in the nursing home for at least 1 y before the beginning of the study. The procedures followed in this study were in accord with the Helsinki Declaration of 1975 as revised in 1983.
Experimental design
An experimental milk formula for elderly subjects supplemented with ®sh oil was developed for this study. The dietary product was a non-commercialized powder milk formula with 1% microencapsulated ®sh oil added. Fat content was 16 g/100 g of powder and was a blend of milk fat, vegetable fat and ®sh oil. Other nutritional components supplied by 100 g of powder were: 29 g of protein, 48 g of carbohydrates, 0.46 g of lecithin, 7.57 mg of a-tocopherol, and also calcium as calcium phosphate, magnesium, sodium, vitamins C, B 6 , B 9 , B 12 , A and D, arti®cial¯avours and asparthame. Calcium and magnesium were added as preventives against bone loss and muscular degenerative diseases (Polley et al, 1987; Smith et al, 1989) . Daily ingestion of 1000 ml of the dietary product provided 100% of the recommended dietary allowances (RDA) (NRC, 1989) for minerals and vitamins. The milk formula was the only dietary variable to change during the study. The milk was always prepared by the staff of the center, dissolving 25 g of powder in 250 ml of hot water per person, and was ingested by the subjects four times a day. Total milk intake per subject per day was 1000 ml and ®sh oil ingestion was 1 g/d. The study was conducted over 15 months. During the course of the study ®ve subjects had to leave the experiment for various reasons, thus 45 subjects (18 men, 27 women) ®nished the experiment.
Fatty acid composition of plasma and erythrocytes was analysed to measure n-3 PUFA incorporation in blood lipids. Although the dietary product was supplemented with a-tocopherol, concentrations of a-tocopherol and retinol in plasma and erythrocytes were also determined in order to detect any undesirable oxidative effect in the body. Blood samples to determine these parameters were obtained the day before the beginning of the experimental period and at the end of that period. Subjects baseline parameters before the experimental diet were used as control. To examine the effects of age on n-3 PUFA incorporation, subjects were divided into two age groups: the lower age bracket (ages 60±80 y, n 21) and the higher age bracket (over 80 y, n 24). Laboratory tests were performed periodically. Biochemical measurements in plasma included total cholesterol, low-density lipoprotein cholesterol (LDL-cholesterol), high-density lipoprotein cholesterol (HDL-cholesterol), triglycerides, albumin, glucose, creatinine, total bilirubin, g-glutamyltransferase, alkaline phosphatase, aspartate amino transferase, and alanine amino transferase. Haematologic analyses included red blood cell count, haemoglobin, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin, platelet count and white cell count.
Dietary assessment
Subjects residing in the nursing home received a constant diet, which consisted in three weekly menus (A, B and C) served in rotation. Dishes were prepared following wellknown recipes widely consumed in Spain. Four meals per day were given and usually no additional food was eaten. Meals were cooked by the staff of the center following strict protocols of preparation in order to maintain a constant diet. The diet was designed by nutritionists to meet recommendations on nutrient intakes for adults (fat 30%, protein 10±15%, and carbohydrates 55±75% of energy intake) (NRC, 1989; WHO, 1990) and to provide at least the RDA for known essential nutrients.
The nutrient composition of the diet is presented in Table 1 . Protein and carbohydrate contents of individual dishes were calculated by means of food composition tables (Mataix, 1994) . In contrast, lipid composition of the individual dishes was veri®ed by chemical analysis, in order to assess the lipid intakes of the subjects. Cooked dishes were individually blended and homogenized and the following parameters were analysed: total fat, fatty acids, cholesterol and a-tocopherol content (unpublished results). The weights of all the ingredients of the diet were recorded, and cooked dishes served and returned by subjects in each meal were also weighed for six consecutive weeks to determine the average ingestion of each cooked dish by individuals. Nutrient daily intakes were determined and the results for all days were averaged to obtain daily intakes.
Fatty acid composition of the experimental milk formula was analysed. Lipid extraction was carried out using dichloromethane : methanol (2 : 1, V/V), according to the method proposed by Chen et al (1981) . Fatty acid methyl esters were prepared by using BF 3 -methanol (Metcalfe et al, 1966) and were quanti®ed by capillary gas chromatography.
Blood analysis
Blood samples were collected after a 12 h overnight fast in EDTA-containing vacutainer tubes by venipuncture. Plasma and erythrocytes were separated by centrifugation at 3000 g for 5 min. Plasma was removed and erythrocytes were washed three times with a saline solution with EDTA K 3 and were ®nally resuspended to an haematocrit of about 45%. Both plasma and erythrocytes were stored under nitrogen at 770 C. Serum total cholesterol and triglyceride concentrations were measured by enzymatic colorimetric methods using commercial kits (CHOD-PAP for cholesterol and GPO-PAP for triglycerides; Boehringer-Mannheim, Mannheim, Germany). Serum HDL-cholesterol was determined in the supernatant after precipitation with phosphotungstic acid and magnesium chloride. LDL-cholesterol was calculated according to Friedewald's equation (Friedewald et al, 1972) .
Plasma and erythrocyte fatty acids were directly transesteri®ed without previous lipid extraction adapting the method proposed by Lepage & Roy (1986) . In brief, 100 ml of plasma or 200 ml of erythrocyte samples were taken. After freeze drying, 2 ml of methanol : toluene solution and 200 ml of acethylchloride were added to the sample. The tubes were incubated in a water bath at 100 C for 1 h. An internal standard (heptadecanoic acid methyl ester) was also added as a check for leakage. After transesteri®cation the toluene phase containing fatty acid methyl esters was transferred into a polypropylene tube and was injected into the gas±liquid chromatograph shortly afterwards. Separation was performed on a Shimadzu gas chromatograph (Kyoto, Japan) equipped with a¯ame ionization detector, and a 30 m 6 0.25 mm I.D. SP-2330 (Supelco) fused silica capillary column was used under the following conditions: initial oven temperature was 120 C for 5 min and then a rise of 2 C/min until 230 C with a ®nal hold for 20 min. Injector and detector temperatures were 250 C and 270 C, respectively. Linear velocity of carrier gas was 20 cm/s, air and hydrogen¯ow-rates were adjusted to give the maximum detector response, and the split rate was 1 : 20. Fatty acids were quanti®ed by internal normalization.
Determination of a-tocopherol and retinol in plasma and erythrocytes was performed by reversed-phase HPLC (Gonza Âlez-Corbella et al, 1994) . a-tocopherol acetate and retinyl acetate were used as internal standards. The analysis was carried out using a Hewlett-Packard liquid chromatographic system equipped with an HP-1050 pump system, and the detector was an HP-1040M photodiode-array detector. The analytical column was Spherisorb ODS-2 (250 6 4.6 mm ID; 5 mm particle size), which was protected by a guard cartridge (C18, 5 mm) system (Tracer, Analitica). Analytical conditions were: isocratic elution with methanol at a¯ow rate of 1 ml/min, column temperature was 50 C, injection volume was 50 ml. Detection was performed at 292 nm for a-tocopherol and at 323 nm for retinol.
Statistical methods
Data are expressed as mean values (s.d.) in all tables. All biochemical data were examined for normality and variance homogeneity before any further statistical analysis. Differences between values before and after ingestion of ®sh oil were assessed by paired t test. A two-sided P valuè 0.05 was considered signi®cant. Analyses were performed by using Statgraphics v.7.0 computer software program (STSC Inc and Statistical Graphics Corporation, US).
Results
The composition of each weekly menu and average total composition of the normal diet in the nursing home are given in Table 1 . There were no signi®cant differences between the three menus (P`0.05, analysis of variance, Anova). Fat, protein and carbohydrate intakes were within the range of recommendations for adults (NRC, 1989) .
The milk formula was tolerated by all subjects without any adverse effects. The compliance of the participants in the study was excellent and they ingested milk formula without dif®culty. Body weight did not vary signi®cantly throughout the study (baseline, 58.4 AE 9.4 kg; 15 mon, 57.90 AE 10.6 kg). Mean values for all biochemical and haematologic indices remained within normal ranges. The fatty acid composition of formula lipid fraction was determined and is presented in Table 2 . Mean contents of EPA and DHA were 1.13% and 0.57% of total fatty acids, respectively. The formula provided 0.40 g/d of total n-3 PUFA, which represented 36% of total n-3 PUFA intake per day. The ratio a-tocopherol/PUFA in the formula was higher than 0.40 mg/g, which is considered adequate according to the US RDA for PUFA protection against oxidation (NRC, 1989) .
Plasma total fatty acid composition before and after the study is presented in Table 3 . The 15 mon administration of the ®sh oil supplemented formula induced a 32% increase of total plasma n-3 PUFA, and a 21% decrease in the n-6/ n-3 ratio. The plasma fatty acids that increased most were, in this order, EPA, docosapentaenoic acid (DPA) and DHA. Linoleic (LA, 18 : 2n-6) and arachidonic (AA, 20 : 4n-6) fatty acid concentrations remained unchanged at the end of the studied period. Erythrocyte fatty acid patterns are shown in Table 4 . Although less pronounced than in plasma, consumption of the formula was associated with a signi®cant increase of 18% in total n-3 fatty acids and a 16% decrease in the n-6/n-3 ratio. Percentages of EPA and DHA also increased signi®cantly (P`0.05). No signi®cant changes were observed in the remaining fatty acid concentrations.
Differences in n-3 PUFA incorporation between subjects in the lower age bracket (ages 60±80 y, n 21) and those in the higher age bracket (over 80 y, n 24) were examined (Table 5 ). Fish oil ingestion had a more pronounced SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; P/S ratio, polyunsaturated/saturated fatty acids ratio. a A, B and C corresponding to the three weekly menus served in rotation in the nursing home. b Values were derived from food composition tables.
Administration of low doses of ®sh oil M Rodrõ Âguez-Palmero et al effect on younger subjects, since they had a higher incorporation of n-3 PUFA than older subjects. EPA concentrations in younger subjects increased signi®cantly (P`0.05) by 109% and 49% in plasma and erythrocytes, respectively, and in older subjects EPA increased signi®cantly by 53% in plasma. Changes in plasma and erythrocyte DHA concentrations were not statistically signi®cant, but they remained higher in younger subjects. Table 6 shows the distribution of retinol and a-tocopherol in plasma and erythrocytes. Milk formula ingestion had no effect on plasma vitamin concentrations. In contrast, the 15 mon ingestion of the formula resulted in a signi®cant increase in a-tocopherol concentrations in erythrocytes from 6.77±7.19 mmol/l. a-tocopherol/PUFA ratio in erythrocytes was also signi®cantly higher at the end of the intervention period. Table 7 shows values of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides at baseline and at 15 mon. Addition of ®sh oil had no signi®cant effect on either variable.
Discussion
In this study we have found that low doses of n-3 PUFA supplemented with adequate amounts of a-tocopherol can be incorporated into blood lipids in elderly subjects without lowering their antioxidant concentrations. A modi®ed milk formula was designed to provide low amounts of ®sh oil, which might have a bene®cial effect in cardiovascular disease and other diseases common among elderly people (Kinsella et al, 1990; Simopoulos, 1991) . In addition, the formula also provided essential nutrients for elderly subjects, such as minerals and vitamins. The dietary product was ingested by the subjects for a relatively long period of time (15 mon). Since the study was conducted in a nursing home, food consumption of the subjects was controlled during the entire study by means of a constant and balanced diet. Initial plasma and erythrocyte n-3 PUFA concentrations in the subjects were within the normal range of data found in the literature on adults (Manku et al, 1983; Cobiac et al, 1991; Nordo Èy et al, 1993) .
The amount of ®sh-derived n-3 PUFA in the present study (0.40 g n-3 PUFA/d) was very low and only comparable with that of a few studies, in which n-3 PUFA doses ranged from % 0.55±2 g/d (Bronsgeest-Schoute et al, 1981; 8.24 C18 : 1 n-9/n-7 28.91 C18 : 2 n-6 11.79 C20 : 0 0.11 C18 : 3 n-3 0.12 C20 : 1 n-9 0.67 C20 : 4 n-6 0.13 C20 : 5 n-3 1.13 C22 : 5 n-3 0.14 C22 : 6 n-3 0. Signi®cantly different from baseline (paired t-test): *P`0.05; **P`0.01. Signi®cantly different from baseline (paired t test): *P`0.05; **P`0.01. Blonk et al, 1990; DeLany et al, 1990; Brown et al, 1991) . Because no large effects were expected, analyses of fatty acids and vitamins were performed at the beginning and at the end of the ingestion period. In spite of the low amounts of n-3 PUFA administered in our study, the dietary product was ingested over a long period of time, and increases in percentages of EPA and DHA were observed. Such increases were modest but they were signi®cant, indicating the incorporation of n-3 PUFA in plasma and also in erythrocyte lipids in elderly subjects. These results are of particular interest, since previous studies of the effects of ®sh oil supplementation were performed in adult populations, and cellular turnover and, therefore, n-3 PUFA incorporation, were expected to be reduced in the elderly. In addition, the results showing the modi®cation in the fatty acid composition of erythrocyte membranes are a better marker of n-3 PUFA incorporation in the tissues than changes in the composition of plasma. In erythrocytes, these modi®cations can induce changes in eicosanoid formation as well as enhanced deformability and reduced blood viscosity (Cartwright et al, 1985) , which are bene®cial effects in cardiovascular diseases. In the present study, concentrations of DHA were not so greatly affected by ®sh oil ingestion as were those of EPA, in both plasma and erythrocytes. These differences might be explained by the different content of these fatty acids in the milk formula or also, in the case of erythrocytes, by the distribution of EPA and DHA in erythrocyte membranes, where EPA is preferentially distributed in the outer membrane, whereas DHA is preferentially distributed on the inner monolayer (Brown et al, 1991) . Furthermore, we found that ®sh oil ingestion had a more pronounced effect on younger subjects, since percentages of increase of n-3 fatty acids in plasma and erythrocytes were higher than in older subjects. These differences between younger and older subjects might be due to the reduction in absorption and other physiological functions with age (Russell, 1992) . As occurred in the entire population, in both age groups n-3 fatty acid increases were higher in plasma than in erythrocytes, and EPA was the fatty acid that increased most.
The results of the present study of the effect of n-3 PUFA supplements on plasma and erythrocyte fatty acid patterns are in agreement with others, in which low doses of n-3 PUFA led to increases in n-3 fatty acids in both plasma (Bronsgeest-Schoute et al, 1981; Blonk et al, 1990; DeLany et al, 1990) and erythrocytes (Brown et al, 1991) comparable to ours. Moreover, as observed in other studies, the low ®sh-oil dose administered in our study did not affect the proportion of LA and AA either in plasma or in erythrocytes (Bronsgeest-Schoute et al, 1981; von Schacky et al, 1985; DeLany et al, 1990) . In this sense, some authors have revealed that EPA and DHA may increase quickly (within 2 weeks) in serum phospholipids in response to relatively low doses of n-3 fatty acids, whereas concentrations of LA and AA only decrease at higher doses (DeLany et al, 1990) .
n-3 PUFA are highly susceptible to oxidation (Halliwell & Chirico, 1993; Benzie, 1996) , and therefore, long term supplementation without adequate antioxidant protection may result in in vivo peroxidation of n-3 fatty acids and thereby produce oxidative damage in elderly subjects, possibly contributing to the development of age-associated diseases (Halliwell, 1987) . This situation is aggravated by the fact that older subjects are also more susceptible to the oxidative process than younger subjects (Meydani, 1992) . Although the dietary formula developed in this study was supplemented with a-tocopherol (7.57 mg/100 g powder), concentrations of a-tocopherol and retinol in plasma and erythrocytes were determined as a safety measure. In agreement with other studies (Haglund et al, 1991; Nair et al, 1993) , it was found that a-tocopherol and retinol concentrations in plasma remained unchanged, whereas atocopherol concentration in erythrocytes was higher at the end of the period studied. This, together with the increase in the a-tocopherol/PUFA ratio after ®sh oil ingestion, suggest that n-3 PUFA-enriched membranes might be ef®ciently protected against peroxidation through the increased level of a-tocopherol. In some studies conducted on rats, it was observed that when low doses of ®sh oil supplemented with a-tocopherol were given, a-tocopherol increased considerably in erythrocytes (Garrido et al, 1993) , and in heart (Chautan et al, 1990) as its membranes became enriched with n-3 PUFA. The administration of an adequate quantity of vitamin E has also been reported to promote some of the bene®cial effects of ®sh oil (Haglund et al, 1991) . In our study plasma lipid parameters (Table 7) were not affected by low dose ®sh oil ingestion, which is consistent with observations reported elsewhere (Bronsgeest-Schoute et al, 1981; DeLany et al, 1990) . In contrast, some studies have reported changes in triglyceride (Schmidt et al, 1990; Eritsland et al, 1995) and in total-cholesterol concentrations (Schaefer et al, 1996) after consumption of low doses of n-3 PUFA.
Although many studies have revealed that ®sh oil has potential bene®cial effects as adjuvant to treatment of coronary heart disease and other diseases, low amounts such as the ones administered in this study might have a preventive role, delaying the appearance of such disorders in elderly subjects. Epidemiological reports have suggested that ®sh consumption corresponding to the modest amounts of n-3 PUFA in this study, if consumed regularly over extended time periods, can protect against cardiovascular disease when compared with no ®sh intake at all (Kromhout et al, 1985; Shekelle et al, 1985; Nelson et al, 1991) . Moreover, it has been reported that moderate intake of n-3 fatty acids remain in the blood lipids long after the cessation of treatment (Brown et al, 1991) .
Conclusions
These ®ndings indicate that small amounts of ®sh oil given to elderly subjects may induce changes in the fatty acid composition of plasma and erythrocytes. Supplementation with adequate levels of antioxidants ensures the antioxidant balance in the subjects. More studies are needed to determine if ®sh oil administration affects platelet function in such low doses.
